Minister Jean-François Roberge told reporters on Wednesday that gender-inclusive writing in communications intended for the public from the education and health-care systems would also be banned in ...
REDMOND, Wash., Sept. 24, 2025 /PRNewswire/ -- SystImmune, Inc. (SystImmune), a clinical-stage biotechnology company, today announced the presentation of data on iza-bren (izalontamab brengitecan) and ...
Strike 3 Holdings is suing Meta in federal court, alleging the tech giant pirated copyrighted adult videos to train its AI models. Strike 3 alleges Meta’s motive was partly to obtain otherwise ...
The linguistic relativity hypothesis is one of the most hotly debated theories in psychology. According to this theory, the specifics of the language that you speak can shape how you think, in ...
And with recent price cuts putting the Long Range Cybertruck, Tesla’s entry-level version of its matte steel monstrosity, at just under $70,000, any potential buyers could just grab a brand new one ...
BOSTON and LONDON, July 23, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel immuno-oncology payload antibody drug conjugates (ADCs) ...
After years of lavishing praise on the Russian leader, President Trump abruptly changed his posture amid mounting frustration with the lack of progress on a cease-fire. By Minho Kim Reporting from ...
LNCB74 is undergoing a Phase 1 study, highlighting NextCure's commitment to developing novel cancer therapies. The presentation of trial results at ASCO emphasizes the significance and visibility of ...
An observational study on the usage of GLP-1 in breast cancer patients in the US. Time-dependent prediction model using modified DeepSurv algorithm for dynamic risk assessment of post-operative bone ...